Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.
van der Ende NAM, Roozenbeek B, Smagge LEM, Luijten SPR, Aerden LAM, Kraayeveld P, van den Wijngaard IR, Lycklama À Nijeholt GJ, den Hertog HM, Flach HZ, Postma AA, Roosendaal SD, Krietemeijer GM, Yo LSF, de Maat MPM, Nieboer D, Del Zoppo GJ, Meurer WJ, Lingsma HF, van der Lugt A, Dippel DWJ; DUMAS Investigators. van der Ende NAM, et al. JAMA Neurol. 2023 Jul 1;80(7):714-722. doi: 10.1001/jamaneurol.2023.1262. JAMA Neurol. 2023. PMID: 37213122 Free PMC article. Clinical Trial.
National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke.
Chalos V, van der Ende NAM, Lingsma HF, Mulder MJHL, Venema E, Dijkland SA, Berkhemer OA, Yoo AJ, Broderick JP, Palesch YY, Yeatts SD, Roos YBWEM, van Oostenbrugge RJ, van Zwam WH, Majoie CBLM, van der Lugt A, Roozenbeek B, Dippel DWJ; MR CLEAN Investigators. Chalos V, et al. Among authors: van der ende nam, van zwam wh, van der lugt a, van oostenbrugge rj. Stroke. 2020 Jan;51(1):282-290. doi: 10.1161/STROKEAHA.119.026791. Epub 2019 Dec 4. Stroke. 2020. PMID: 31795895 Free PMC article. Clinical Trial.
Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.
van der Ende NAM, Roozenbeek B, Berkhemer OA, Koudstaal PJ, Boiten J, van Dijk EJ, Roos YBWEM, van Oostenbrugge RJ, Majoie CBLM, van Zwam W, Lingsma HF, van der Lugt A, Dippel DWJ; MR CLEAN Investigators. van der Ende NAM, et al. Among authors: van der lugt a, van zwam w, van oostenbrugge rj, van dijk ej. Stroke. 2022 Jan;53(1):61-69. doi: 10.1161/STROKEAHA.121.035301. Epub 2021 Oct 5. Stroke. 2022. PMID: 34607469 Free PMC article. Clinical Trial.
Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort Study.
van der Steen W, van der Ende NAM, van Kranendonk KR, Chalos V, van Oostenbrugge RJ, van Zwam WH, Roos YBWEM, van Doormaal PJ, van Es ACGM, Lingsma HF, Majoie CBLM, van der Lugt A, Dippel DWJ, Roozenbeek B; MR CLEAN Trial and MR CLEAN Registry Investigators. van der Steen W, et al. Among authors: van der ende nam. Stroke. 2022 Sep;53(9):2818-2827. doi: 10.1161/STROKEAHA.121.036195. Epub 2022 Jun 8. Stroke. 2022. PMID: 35674042 Free PMC article. Clinical Trial.
Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.
van der Ende NAM, Roozenbeek B, Smagge LEM, Luijten SPR, Aerden LAM, Kraayeveld P, van den Wijngaard IR, Lycklama À Nijeholt GJ, den Hertog HM, Flach HZ, Wallace AC, Gurewich V, Del Zoppo GJ, Meurer WJ, Lingsma HF, van der Lugt A, Dippel DWJ; DUMAS Investigators. van der Ende NAM, et al. Trials. 2022 Aug 9;23(1):641. doi: 10.1186/s13063-022-06596-z. Trials. 2022. PMID: 35945566 Free PMC article.
Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcome.
van der Steen W, van der Ende NAM, Luijten SPR, Rinkel LA, van Kranendonk KR, van Voorst H, Roosendaal SD, Beenen LFM, Coutinho JM, Emmer BJ, van Oostenbrugge RJ, Majoie CBLM, Lingsma HF, van der Lugt A, Dippel DWJ, Roozenbeek B; MR CLEAN-NO IV, MR CLEAN-MED, and CONTRAST investigators. van der Steen W, et al. Among authors: van der ende nam. J Neurointerv Surg. 2023 Oct;15(10):971-976. doi: 10.1136/jnis-2022-019474. Epub 2022 Oct 19. J Neurointerv Surg. 2023. PMID: 36261280 Free PMC article.
Infarct volume after ischemic stroke as a mediator of the effect of endovascular thrombectomy on early postprocedural neurologic deficit.
Samuels N, Compagne KCJ, van der Ende NAM, Chalos V, Konduri PR, van Doormaal PJ, van Zwam WH, Majoie CBLM, Marquering HA, Roozenbeek B, Lingsma HF, Dippel DWJ, van der Lugt A; MR CLEAN investigators. Samuels N, et al. Among authors: van der ende nam. J Stroke Cerebrovasc Dis. 2023 Feb;32(2):106906. doi: 10.1016/j.jstrokecerebrovasdis.2022.106906. Epub 2022 Dec 5. J Stroke Cerebrovasc Dis. 2023. PMID: 36473395 Clinical Trial.
Timing of symptomatic intracranial hemorrhage after endovascular stroke treatment.
van der Steen W, van der Ende NA, van Kranendonk KR, Chalos V, Brouwer J, van Oostenbrugge RJ, van Zwam WH, van Doormaal PJ, van Es AC, Majoie CB, van der Lugt A, Dippel DW, Roozenbeek B. van der Steen W, et al. Eur Stroke J. 2022 Dec;7(4):393-401. doi: 10.1177/23969873221112279. Epub 2022 Aug 3. Eur Stroke J. 2022. PMID: 36478761 Free PMC article.
16 results